Biblio Discovery — Demo Discovery Service

3 results for "Niu, Li-Ting"

Showing 1–3 · 0.82 seconds · RSS

  1. Journal Article Full text

    Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification

    Zhao, Yijing; Niu, Li-Ting; Hu, Li-Juan et al.

    Front Oncol · 2022 · English · PubMed Central

    BACKGROUND: Enoyl-CoA hydratase domain containing 3 (ECHDC3) increased in CD34(+) progenitor cells of acute myeloid leukemia (AML) cells after chemotherapy. However, the prognostic significance and function of ECHDC3 in AML remain to be clarified. METHODS: In the training cohort, 24 AML (non-acute…

  2. Journal Article Full text

    Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage

    Niu, Li-Ting; Wang, Yu-Qing; Wong, Catherine C.L. et al.

    Transl Oncol · 2021 · English · PubMed Central

    The persistence of leukemia stem cells (LSCs) is one of the leading causes of chemoresistance in acute myeloid leukemia (AML). To explore the factors important in LSC-mediated resistance, we use mass spectrometry to screen the factors related to LSC chemoresistance and defined IFN-γ-inducible…

  3. Journal Article Full text

    Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36–inflammatory monocyte axis

    Guo, He-Zhou; Guo, Zi-Hua; Yu, Shan-He et al.

    Sci Adv · 2021 · English · PubMed Central

    Chemotherapy can effectively reduce the leukemic burden and restore immune cell production in most acute myeloid leukemia (AML) cases. Nevertheless, endogenous immunosurveillance usually fails to recover after chemotherapy, permitting relapse. The underlying mechanisms of this therapeutic failure…